Search





Search





Markets
/
Stocks
/
nasdaq-tmo
/

Thermo Fisher Scientific Inc

TMO

Add to Watchlist

469.130USD

+5.120+1.10%

Close 06/23, 16:00（ET）Quotes delayed by 15 min

174.42BMarket Cap

25.73P/E TTM

Thermo Fisher Scientific Inc

469.130

+5.120+1.10%

Overview

Financials

Discussions

Analysis

Company

View Detailed Chart

TradingKey 图表

Intraday

30m

Today

+1.10%

5 Days

-0.74%

1 Month

+4.65%

6 Months

-19.11%

Year to Date

-19.04%

1 Year

+17.22%

Key Figures

469.900Open

471.120High

1.82MVolume

25.73P/E TTM

17.33P/E Dynamic

1.760Dividend TTM

0.49%Turnover Ratio

464.010Prev. Close

461.330Low

369.94MTurnover

27.52P/E Static

3.36P/B

0.38%Div Yield TTM

6.47%ROA

643.99052wk High

0.88Volume Ratio

6.33BNet Profit

371.62MShares

18.2339EPS TTM

0.88Beta

13.52%ROE

385.46052wk Low

2.11%Amplitude

40.25%Gross Margin

174.42BMarket Cap

2.10Reward/Risk

1.67%Risk Rate

TradingKey Stock Score of Thermo Fisher Scientific Inc

Currency: USD Updated: 2026-06-23

Key Insights

Thermo Fisher Scientific Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 3 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 605.94.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Thermo Fisher Scientific Inc's Score

Industry at a Glance

Industry Ranking

3 / 204

Overall Ranking

32 / 4573

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

38°C



Very Low

Very High

Positive

Thermo Fisher Scientific Inc Highlights

StrengthsRisks

Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. It also provides purification and filtration technologies.

Industry Leader

The company's revenue leads the industry, with the latest annual revenue totaling USD 44.56B.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 9.41%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 9.41%.

Undervalued

The company’s latest PE is 25.74, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 353.25M shares, decreasing 0.73% quarter-over-quarter.

Held by EDGEPOINT CANADIAN PORTFOLIO

Star Investor EDGEPOINT CANADIAN PORTFOLIO holds 2.07M shares of this stock.